Invention Grant
- Patent Title: 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
-
Application No.: US16504375Application Date: 2019-07-08
-
Publication No.: US11192877B2Publication Date: 2021-12-07
- Inventor: Claire Adcock , Simone Bonazzi , Artiom Cernijenko , Philip Lam , Kathryn Taylor Linkens , Hasnain Ahmed Malik , Noel Marie-France Thomsen , Michael Scott Visser
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D407/14
Abstract:
The present disclosure provides a compound of Formula (I′): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein Rx, X1, X2, and R1 are as defined herein, and methods of making and using same.
Public/Granted literature
- US20200017461A1 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Public/Granted day:2020-01-16
Information query
